Transthyretin amyloidosis (ATTR) is a rare and progressive disorder caused by the accumulation of misfolded transthyretin proteins in different organs, particularly the heart and peripheral nerves. Although once considered difficult to diagnose and manage, advances in disease awareness, genetic testing, and targeted therapies have significantly improved the treatment landscape. As healthcare...